https://healthandpharma.net/nectin4-adc-breast-cancer-9mw2821-tnbc-mabwell Health and Pharma en 2026-04-24T00:00:00+00:00 World’s First Nectin-4-Targeting ADC Enters Phase III Trial in Triple-Negative Breast Cancer